# Inflammatix, Inc.

Canonical: https://abierto.us/vendors/inflammatix-inc-wk9mlmshbvl3

- UEI: WK9MLMSHBVL3
- CAGE: 7Q4D9
- Location: Burlingame, CA
- Awards in window: 2 (5 transactions), -$1 obligated, January 23, 2024 to March 11, 2026

## Awarding agencies

- Office of Assistant Secretary for Preparedness and Response: 2 awards, -$1

## Industries

- 541714 Research and Development in Biotechnology (except Nanobiotechnology): -$1

## Competition

- Full and Open Competition: 2 awards

## Largest awards

- 75A50122C00069 (definitive contract): $0, Barda - Aspr / Daappo / Barda DCMA. Inflammatix, INC. R&D for Triverity Cartridge Development Aoi #2 (Infection Severity and Solving Sepsis). https://www.usaspending.gov/award/CONT_AWD_75A50122C00069_7505_-NONE-_-NONE-/
- 75A50119C00034 (definitive contract): -$1, Barda - Aspr / Daappo / Barda DCMA. Add Supplemental Funding. https://www.usaspending.gov/award/CONT_AWD_75A50119C00034_7505_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/inflammatix-inc-wk9mlmshbvl3.